AUTONOMIC DIABETIC NEUROPATHY
This article is informed about autonomic diabetic neuropathy, its classification, clinical manifistations, pathogenic and symp-tomatic aspects of therapy.
A.A. Dyusupova, G.Zh. Bayadilova, M.D. Shotikov, A.A. Buzhikenova
General medicine on PG course SSMU
1. Мельчинская Е.Н. Диабетическая нейропатия и значение нейротропных витаминов в ее лечении // Диа-бетология. – 2010. – С.2-7.
2. Дедов И.И., Мельниченко Г.А. Эндокринология. Национальное руководство / Под ред. Дедова И.И., Мельниченко Г.А. – 2008. – 400с.
3. Boulton AJM, Rayaz Malik, Arezzo JCA, Sosenko JM. Diabetic Somatic Neuropathies. Diabetes Care 2004; 27: 1458–86.
4. Ziegler D.Diabetic cardiovascular autonomic neu-ropathy: Prognosis, diagnosis and treatment. Diabetes Metab. Rev. 1994;10(4):339-83.
5. Said G. Different patterns of neuropathies in dia-betic patients. Diabetic Neuropathy. Boulton AJM, Ed. Co-logne, Aventis, Academy Press. - 2001. - P. 16–41.
6. Галстян Г.Р., Анциферов М.Б. Лечение диабе-тической полинейропатии // Врач. - 2000. – С.23–9.
Number of Views: 141
Bibliography link
Related publications:
IMMUNOLOGICAL CHANGES IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY